Planned 7467-share insider sale filed for HRTG (NYSE: HRTG)

Rhea-AI Filing Summary

A shareholder of HRTG has filed a Form 144 to sell common stock. The notice covers 7467 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of 195038.04. The shares relate to restricted stock units acquired from the issuer on 11/14/2016, matching the 7467-share amount.

The filing notes that 30911435 shares of common stock were outstanding and lists the NYSE as the exchange, with an approximate sale date of 01/20/2026. It also details recent sales over the prior three months by Ernesto Garateix and related 10b5-1 plans, including multiple transactions in November and December 2025 with stated gross proceeds. The signer represents they do not know of any undisclosed material adverse information about the issuer.

Insights

Insider trading and governance analyst

Form 144 shows a planned 7467-share sale tied to prior RSU awards and recent 10b5-1 activity, but is routine in nature.

The filing indicates a shareholder intends to sell 7467 common shares of HRTG through Morgan Stanley Smith Barney LLC, valued at 195038.04. These shares stem from restricted stock units acquired from the issuer on 11/14/2016, suggesting the sale is linked to long-standing equity compensation rather than a new issuance. Shares outstanding were 30911435 as of the data provided, which helps frame the sale as relatively small versus the overall equity base.

The document also lists multiple sales in the prior three months by Ernesto Garateix and related 10b5-1 arrangements, with individual trades such as 7000 shares on 12/09/2025 for gross proceeds of 198537.50 and 10000 shares on 11/11/2025 for 290976.00. The representation that the seller does not know of undisclosed material adverse information, and the use of 10b5-1 plans in several entries, both point to prearranged, compliance-oriented selling rather than a clearly reactive move. Overall, this appears to be standard insider liquidity activity without clear, thesis-changing implications.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7467	195038.04	30911435	01/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2016	Restricted Stock Units	Issuer			7467	11/14/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERNESTO GARATEIX & YVETTE GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	12/22/2025	7467	220118.95
10b5-1 Sales for ERNESTO J GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	12/22/2025	867	25549.71
ERNESTO GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	12/12/2025	1709	49298.33
ERNESTO GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	12/11/2025	6291	178814.13
ERNESTO GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	12/09/2025	7000	198537.50
10b5-1 Sales for ERNESTO GARATEIX & YVETTE GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	11/20/2025	7467	201152.77
10b5-1 Sales for ERNESTO J GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	11/20/2025	867	23343.54
ERNESTO GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	11/13/2025	5000	153848.00
ERNESTO GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	11/12/2025	5000	151950.00
ERNESTO GARATEIX 1401 N. Westshore Blvd Tampa FL 33607	Common	11/11/2025	10000	290976.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does HRTG's latest Form 144 filing disclose?

The Form 144 discloses a planned sale of 7467 shares of HRTG common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 195038.04 and an approximate sale date of 01/20/2026 on the NYSE.

How were the 7467 HRTG shares in the Form 144 originally acquired?

The 7467 HRTG shares covered by the Form 144 relate to restricted stock units acquired from the issuer on 11/14/2016, with the amount of securities acquired listed as 7467 and the nature of payment shown as N/A.

How many HRTG common shares were outstanding according to the Form 144?

The Form 144 states that the number of HRTG common shares outstanding was 30911435, providing context for the size of the planned 7467-share sale.

What recent HRTG stock sales by the filer are listed in the past 3 months section?

The filing lists several recent sales, including 7000 shares on 12/09/2025 for gross proceeds of 198537.50 and 10000 shares on 11/11/2025 for 290976.00, along with multiple 10b5-1 sales entries for Ernesto Garateix and Ernesto & Yvette Garateix.

Are any of the HRTG stock sales made under Rule 10b5-1 trading plans?

Yes. The past 3 months table includes entries labeled "10b5-1 Sales" for Ernesto Garateix and Ernesto & Yvette Garateix, indicating that several of the listed transactions were executed under Rule 10b5-1 plans.

What representation does the seller make about HRTG's non-public information in the Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed, and this representation also applies as of any Rule 10b5-1 plan adoption date.